Share
Market Research Report

RARE DISEASE DIAGNOSTICS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

Segmentation
  • By Test TypeGenetic Testing · Biochemical Testing · Molecular Diagnostics · Imaging Diagnostics · Others
  • By TechnologyNext-Generation Sequencing (NGS) · Polymerase Chain Reaction (PCR) · Sanger Sequencing · Microarray · Mass Spectrometry · Immunoassays · Others
  • By Disease TypeNeurological Disorders · Metabolic and Endocrine Disorders · Hematological Disorders · Immunological Disorders · Cardiovascular Disorders · Genetic Cancers · Musculoskeletal Disorders · Others
  • By Sample TypeBlood · Saliva · Buccal Swab · Urine · Tissue · Cerebrospinal Fluid (CSF) · Others
  • By End UserDiagnostic Laboratories · Hospitals and Clinics · Research and Academic Institutions · Pharmaceutical and Biotechnology Companies · Others
  • By GeographyNorth America · Europe · Asia Pacific · Latin America · Middle East · and Africa
  • Published In22 Sept 2026
  • Report CodeCMI10130
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026 - 2033

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Rare Disease Diagnostics Market, By Test Type
    • Global Rare Disease Diagnostics Market, By Technology
    • Global Rare Disease Diagnostics Market, By Disease Type
    • Global Rare Disease Diagnostics Market, By Sample Type
    • Global Rare Disease Diagnostics Market, By End User
    • Global Rare Disease Diagnostics Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Test Type Launches/Approvals
  • PEST Analysis
  • PORTER’s Analysis
  • Market Opportunities
  • Industry Trends

4. Global Rare Disease Diagnostics Market, By Test Type, 2021-2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Genetic Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Biochemical Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Molecular Diagnostics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Imaging Diagnostics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

5. Global Rare Disease Diagnostics Market, By Technology, 2021-2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Next-Generation Sequencing (NGS)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Polymerase Chain Reaction (PCR)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Sanger Sequencing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Microarray
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Mass Spectrometry
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Immunoassays
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

6. Global Rare Disease Diagnostics Market, By Disease Type, 2021-2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Neurological Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Metabolic and Endocrine Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Hematological Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Immunological Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Cardiovascular Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Genetic Cancers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Musculoskeletal Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

7. Global Rare Disease Diagnostics Market, By Sample Type, 2021-2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Blood
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Saliva
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Buccal Swab
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Urine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Tissue
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Cerebrospinal Fluid (CSF)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

8. Global Rare Disease Diagnostics Market, By End User, 2021-2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Diagnostic Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Hospitals and Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Research and Academic Institutions
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Pharmaceutical and Biotechnology Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

9. Global Rare Disease Diagnostics Market, By Region, 2021 - 2033, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

10. Competitive Landscape

  • Thermo Fisher Scientific Inc.
    • Company Highlights
    • Test Type Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • F. Hoffmann-La Roche Ltd.
    • Company Highlights
    • Test Type Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Quest Diagnostics Incorporated
    • Company Highlights
    • Test Type Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Laboratory Corporation of America Holdings
    • Company Highlights
    • Test Type Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Illumina, Inc.
    • Company Highlights
    • Test Type Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Eurofins Scientific SE
    • Company Highlights
    • Test Type Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • QIAGEN N.V.
    • Company Highlights
    • Test Type Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Agilent Technologies, Inc.
    • Company Highlights
    • Test Type Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bio-Rad Laboratories, Inc.
    • Company Highlights
    • Test Type Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • CENTOGENE N.V.
    • Company Highlights
    • Test Type Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

11. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

12. References and Research Methodology

  • References
  • Research Methodology
  • About us

*Browse 32 market data tables and 28 figures on ‘Rare Disease Diagnostics Market' - Global forecast to 2033